Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing ICSI .
Phase of Trial: Phase III/IV
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Cabergoline (Primary) ; Calcium gluconate
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 24 Sep 2013 New trial record